Successful treatment of eosinophilic esophagitis with upadacitinib prescribed for atopic dermatitis
JPGN Reports · 2026-08 · 7 (3) · 449-451
DOI: 10.1002/jpr3.70170 ↗Kurz gefasst
Fachartikel in der Zeitschrift JPGN Reports, online erschienen am 03.04.2026. Verfasst von Nathalie Nguyen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pediatric Gastroenterology, Hepatology and Nutrition, Digestive Health Institute, Children's Hospital Colorado Aurora Colorado USA. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We describe a pediatric patient treated with upadacitinib for atopic dermatitis (AD) who subsequently achieved sustained clinical and histologic remission of eosinophilic esophagitis (EoE). Upadacitinib is an oral small molecule selective Janus kinase 1 inhibitor that inhibits janus kinase‐signal transduction and activation of transcription (JAK‐STAT) pathway with wide inhibitory effects on the immune system, including Th2 signaling pathways. Therefore, it leads to broad suppression of inflammatory cytokines, including interleukin‐4 (IL‐4), interleukin‐13 (IL‐13), and thymic stromal lymphopoietin (TSLP), that play a central role in the pathogenesis of EoE. Given the broad signaling pathway, if a patient is started on upadacitinib for other indications, cessation of other therapies, particularly biologics like dupilumab, should be considered on a case‐by‐case basis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Pediatric Gastroenterology, Hepatology and Nutrition, Digestive Health Institute, Children's Hospital Colorado Aurora Colorado USA.
- Department of Pediatrics Gastrointestinal Eosinophilic Diseases Program, University of Colorado School of Medicine Aurora Colorado USA.
- Section of Pediatric Allergy & Immunology, Children's Hospital Colorado Aurora Colorado USA.
ORCID-Profile: Nathalie Nguyen
Zitieren
APA
Nguyen, N., & Bauer, M. (2026). Successful treatment of eosinophilic esophagitis with upadacitinib prescribed for atopic dermatitis. JPGN Reports, 7(3), 449-451. https://doi.org/10.1002/jpr3.70170
Vancouver
Nguyen N, Bauer M. Successful treatment of eosinophilic esophagitis with upadacitinib prescribed for atopic dermatitis. JPGN Reports. 2026;7(3):449-451. doi:10.1002/jpr3.70170
BibTeX
@article{Nguyen2026,
author = {Nguyen, Nathalie and Bauer, Maureen},
title = {Successful treatment of eosinophilic esophagitis with upadacitinib prescribed for atopic dermatitis},
journal = {JPGN Reports},
year = {2026},
volume = {7},
number = {3},
pages = {449--451},
doi = {10.1002/jpr3.70170}
}
EUVIMED